N Honoré, R Galot, C van Marcke, N Limaye… - Cancers, 2021 - ncbi.nlm.nih.gov
One reason why some patients experience recurrent disease after a curative-intent
treatment might be the persistence of residual tumor cells, called minimal residual disease …